Research ArticleBasic Science Investigation
Marrow Toxicity of 33P- Versus 32P-Orthophosphate: Implications for Therapy of Bone Pain and Bone Metastases
S. Murty Goddu, Anupam Bishayee, Lionel G. Bouchet, Wesley E. Bolch, Dandamudi V. Rao and Roger W. Howell
Journal of Nuclear Medicine May 2000, 41 (5) 941-951;
S. Murty Goddu
Anupam Bishayee
Lionel G. Bouchet
Wesley E. Bolch
Dandamudi V. Rao
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Marrow Toxicity of 33P- Versus 32P-Orthophosphate: Implications for Therapy of Bone Pain and Bone Metastases
S. Murty Goddu, Anupam Bishayee, Lionel G. Bouchet, Wesley E. Bolch, Dandamudi V. Rao, Roger W. Howell
Journal of Nuclear Medicine May 2000, 41 (5) 941-951;
Jump to section
Related Articles
- No related articles found.
Cited By...
- MIRD Pamphlet No. 22 (Abridged): Radiobiology and Dosimetry of {alpha}-Particle Emitters for Targeted Radionuclide Therapy
- Dosimetry of 188Re-Hydroxyethylidene Diphosphonate in Human Prostate Cancer Skeletal Metastases
- Targeting of Osseous Sites with {alpha}-Emitting 223Ra: Comparison with the {beta}-Emitter 89Sr in Mice
- Biologic Dosimetry of Bone Marrow: Induction of Micronuclei in Reticulocytes After Exposure to 32P and 90Y
- Marrow-Sparing Effects of 117mSn(4+)Diethylenetriaminepentaacetic Acid for Radionuclide Therapy of Bone Cancer